We found that BOS cells primarily expressed the longer p46 isoform of RUNX3, which plays a tumor suppressor role and might explain the decreased transformation in BOS compared with AML-ASXL1 that expresses the shorter p44 isoform. The gene discussed is RUNX3; the disease is Buschke-Ollendorff syndrome.